(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1314362 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of AXUD1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine affects expression ISO RGD:1314363 6480464 1, 2-Dimethylhydrazine affects the expression of CSRNP1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1314363 6480464 Ethinyl Estradiol results in increased expression of CSRNP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1314363 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSRNP1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1314363 6480464 Estradiol results in increased expression of CSRNP1 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:1314362 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CSRNP1 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:1314362 6480464 Estradiol results in decreased expression of AXUD1 mRNA CTD PMID:19167446 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314363 6480464 Tetrachlorodibenzodioxin results in increased expression of CSRNP1 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CSRNP1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314363 6480464 Tetrachlorodibenzodioxin affects the expression of AXUD1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314363 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSRNP1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314363 6480464 Tetrachlorodibenzodioxin results in decreased expression of CSRNP1 mRNA CTD PMID:19933214 2-hydroxypropanoic acid decreases expression ISO RGD:1314362 6480464 Lactic Acid results in decreased expression of CSRNP1 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1314363 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of AXUD1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1314363 6480464 bis4-hydroxyphenylsulfone results in increased expression of CSRNP1 mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO RGD:1314363 6480464 4-hydroxy-2-nonenal results in decreased expression of AXUD1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1314363 6480464 Fenretinide results in increased expression of CSRNP1 mRNA CTD PMID:28973697 acetaldehyde increases expression ISO RGD:1314362 6480464 Acetaldehyde results in increased expression of CSRNP1 mRNA CTD PMID:23416264 acrolein multiple interactions ISO RGD:1314362 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CSRNP1 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1314363 6480464 Acrylamide results in increased expression of CSRNP1 mRNA CTD PMID:30807115 afimoxifene multiple interactions ISO RGD:1314362 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of AXUD1 mRNA] CTD PMID:21233418 aldehydo-D-glucose increases expression ISO RGD:1314363 6480464 Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 all-trans-retinoic acid multiple interactions ISO RGD:1314363 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CSRNP1 mRNA CTD PMID:30951980 alpha-pinene multiple interactions ISO RGD:1314362 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CSRNP1 mRNA CTD PMID:32699268 antirheumatic drug decreases expression ISO RGD:1314362 6480464 Antirheumatic Agents results in decreased expression of CSRNP1 mRNA CTD PMID:24449571 atrazine increases expression ISO RGD:1314362 6480464 Atrazine results in increased expression of CSRNP1 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1314362 6480464 Benzoapyrene results in increased expression of CSRNP1 mRNA CTD PMID:20064835 , PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1314362 6480464 Benzoapyrene affects the methylation of CSRNP1 5' UTR, Benzoapyrene affects the methylation of CSRNP1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1314363 6480464 Benzoapyrene results in increased expression of CSRNP1 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1314362 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression ISO RGD:1314363 6480464 benzobfluoranthene results in increased expression of CSRNP1 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of CSRNP1 mRNA CTD PMID:15651846 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CSRNP1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1314363 6480464 bisphenol A results in increased expression of CSRNP1 mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:1314362 6480464 bisphenol A results in decreased expression of CSRNP1 mRNA CTD PMID:29275510 bisphenol A decreases expression ISO RGD:1314363 6480464 bisphenol A results in decreased expression of CSRNP1 mRNA CTD PMID:25594700 bisphenol F increases expression ISO RGD:1314363 6480464 bisphenol F results in increased expression of CSRNP1 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1314363 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CSRNP1 mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1314362 6480464 butyraldehyde results in increased expression of CSRNP1 mRNA CTD PMID:26079696 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of CSRNP1 mRNA CTD PMID:22110744 Calcimycin multiple interactions ISO RGD:1314363 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA] CTD PMID:25451590 Calcimycin increases expression ISO RGD:1314363 6480464 Calcimycin results in increased expression of AXUD1 mRNA CTD PMID:25451590 calcitriol multiple interactions ISO RGD:1314362 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CSRNP1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1314362 6480464 Calcitriol results in increased expression of CSRNP1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1314363 6480464 Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CSRNP1 mRNA] CTD PMID:27256343 carbon nanotube affects expression ISO RGD:1314363 6480464 Nanotubes, Carbon analog affects the expression of CSRNP1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1314363 6480464 Nanotubes, Carbon results in decreased expression of CSRNP1 mRNA CTD PMID:25554681 , PMID:25620056 carbon nanotube increases expression ISO RGD:1314363 6480464 Nanotubes, Carbon analog results in increased expression of CSRNP1 mRNA CTD PMID:25620056 cerium trichloride increases expression ISO RGD:1314363 6480464 cerous chloride results in increased expression of AXUD1 mRNA CTD PMID:23573234 choline multiple interactions ISO RGD:1314363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1314362 6480464 Cisplatin results in increased expression of CSRNP1 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1314362 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CSRNP1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1314362 6480464 Cisplatin results in decreased expression of CSRNP1 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1314362 6480464 cobaltous chloride results in increased expression of AXUD1 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CSRNP1 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1314362 6480464 [Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of CSRNP1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions ISO RGD:1314362 6480464 [Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of CSRNP1 mRNA CTD PMID:20971185 , PMID:24690739 copper(II) sulfate increases expression ISO RGD:1314362 6480464 Copper Sulfate results in increased expression of CSRNP1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1314362 6480464 Coumestrol results in decreased expression of AXUD1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1314362 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of AXUD1 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1314362 6480464 Asbestos, Crocidolite results in increased expression of CSRNP1 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1314362 6480464 Asbestos, Crocidolite affects the expression of CSRNP1 mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:1314362 6480464 Cyclosporine results in increased expression of CSRNP1 mRNA CTD PMID:20106945 , PMID:25562108 cytarabine decreases expression ISO RGD:1314362 6480464 Cytarabine results in decreased expression of AXUD1 mRNA CTD PMID:21198554 D-glucose increases expression ISO RGD:1314363 6480464 Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of AXUD1 mRNA CTD PMID:21266533 dieldrin increases expression ISO RGD:1314362 6480464 Dieldrin results in increased expression of CSRNP1 mRNA CTD PMID:31068361 dioxygen multiple interactions ISO RGD:1314363 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRNP1 mRNA CTD PMID:30529165 disulfiram multiple interactions ISO RGD:1314362 6480464 [Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1314362 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CSRNP1 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314363 6480464 Doxorubicin results in increased expression of CSRNP1 mRNA CTD PMID:16243910 , PMID:25896364 doxorubicin decreases expression ISO RGD:1314362 6480464 Doxorubicin results in decreased expression of CSRNP1 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CSRNP1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1314362 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of AXUD1 mRNA CTD PMID:19167446 fluoranthene multiple interactions ISO RGD:1314363 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CSRNP1 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1314363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1314363 6480464 Folic Acid results in decreased expression of CSRNP1 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1314362 6480464 Formaldehyde results in increased expression of CSRNP1 mRNA CTD PMID:23649840 glucose increases expression ISO RGD:1314363 6480464 Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 L-methionine multiple interactions ISO RGD:1314363 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1314362 6480464 leflunomide results in increased expression of CSRNP1 mRNA CTD PMID:28988120 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CSRNP1 mRNA CTD PMID:24136188 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CSRNP1 mRNA CTD PMID:16507785 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CSRNP1 mRNA CTD PMID:30467583 methylisothiazolinone increases expression ISO RGD:1314362 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CSRNP1 mRNA CTD PMID:31629900 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CSRNP1 mRNA CTD PMID:22546817 niclosamide increases expression ISO RGD:1314362 6480464 Niclosamide results in increased expression of CSRNP1 mRNA CTD PMID:28284560 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CSRNP1 mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CSRNP1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1314362 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1314363 6480464 Acetaminophen affects the expression of CSRNP1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1314362 6480464 Acetaminophen results in increased expression of CSRNP1 mRNA CTD PMID:21420995 , PMID:29067470 pentanal increases expression ISO RGD:1314362 6480464 pentanal results in increased expression of CSRNP1 mRNA CTD PMID:26079696 phenobarbital decreases expression ISO RGD:1314363 6480464 Phenobarbital results in decreased expression of CSRNP1 mRNA CTD PMID:19270015 phenylmercury acetate multiple interactions ISO RGD:1314362 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CSRNP1 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1314363 6480464 pirinixic acid results in decreased expression of CSRNP1 mRNA CTD PMID:23811191 potassium chromate multiple interactions ISO RGD:1314362 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of AXUD1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1314362 6480464 potassium chromateVI results in increased expression of AXUD1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1314363 6480464 Pregnenolone Carbonitrile results in increased expression of CSRNP1 mRNA CTD PMID:28903501 propionic acid increases expression ISO RGD:1314362 6480464 propionic acid results in increased expression of CSRNP1 mRNA CTD PMID:31526819 rac-lactic acid decreases expression ISO RGD:1314362 6480464 Lactic Acid results in decreased expression of CSRNP1 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1314362 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CSRNP1 mRNA CTD PMID:27188386 Shikonin multiple interactions ISO RGD:1314363 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of AXUD1 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA] CTD PMID:25451590 silicon dioxide increases expression ISO RGD:1314362 6480464 Silicon Dioxide analog results in increased expression of CSRNP1 mRNA CTD PMID:23806026 silver atom increases expression ISO RGD:1314363 6480464 Silver results in increased expression of CSRNP1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1314363 6480464 Silver results in increased expression of CSRNP1 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1314363 6480464 sodium arsenate results in decreased expression of CSRNP1 mRNA CTD PMID:30953684 sodium dodecyl sulfate increases expression ISO RGD:1314362 6480464 Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of CSRNP1 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1314362 6480464 Sunitinib results in increased expression of CSRNP1 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1314362 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CSRNP1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1314362 6480464 Testosterone results in decreased expression of CSRNP1 mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:1314363 6480464 Tetrachloroethylene results in increased expression of CSRNP1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1314363 6480464 Carbon Tetrachloride results in increased expression of CSRNP1 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:1314362 6480464 Thapsigargin results in increased expression of CSRNP1 mRNA CTD PMID:29453283 titanium dioxide increases expression ISO RGD:1314363 6480464 titanium dioxide results in increased expression of AXUD1 mRNA, titanium dioxide results in increased expression of CSRNP1 mRNA CTD PMID:23409001 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CSRNP1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1314362 6480464 torcetrapib results in increased expression of CSRNP1 mRNA CTD PMID:23228038 triclosan increases expression ISO RGD:1314362 6480464 Triclosan results in increased expression of CSRNP1 mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CSRNP1 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1314363 6480464 troglitazone results in decreased expression of CSRNP1 mRNA CTD PMID:28973697 tunicamycin increases expression ISO RGD:1314363 6480464 Tunicamycin results in increased expression of CSRNP1 mRNA CTD PMID:17127020 urethane increases expression ISO RGD:1314362 6480464 Urethane results in increased expression of CSRNP1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1314362 6480464 Valproic Acid results in decreased methylation of CSRNP1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1314362 6480464 Valproic Acid results in increased expression of CSRNP1 mRNA CTD PMID:28001369 , PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CSRNP1 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1314362 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CSRNP1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1314362 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CSRNP1 mRNA CTD PMID:18593933
